Literature DB >> 16305852

Long segmental reconstruction of diffusely diseased left anterior descending coronary artery with left internal thoracic artery with or without endarterectomy.

Toshihiro Fukui1, Shuichiro Takanashi, Yasuyuki Hosoda.   

Abstract

BACKGROUND: The diffusely diseased left anterior descending coronary artery (LAD) remains a challenge for both interventional cardiologists and cardiac surgeons. In this study we assessed the surgical outcomes obtained from coronary artery reconstruction, with or without endarterectomy, for a diffusely diseased LAD.
METHODS: Two hundred and fifty patients were treated with an extended LAD reconstruction, with or without endarterectomy, as part of coronary artery bypass grafting to achieve complete revascularization. The left internal thoracic artery (LITA) was used to reconstruct the LAD in all patients. There were 197 men and 53 women. The mean age was 65.1 +/- 9.0 years. Coronary artery reconstruction was performed without endarterectomy in 183 patients (73.2%) and with endarterectomy in 67 patients (26.8%). The off-pump technique was used in 204 patients (81.6%).
RESULTS: The operative mortality was 1.6%. Perioperative myocardial infarction was observed in 6.4% of the patients. The mean LAD incision length was 4.3 +/- 1.7 cm. The patency rate of the LITA to LAD was 98.6% by early angiographic examination (mean, 7.5 +/- 2.6 postoperative days). There were 3 late cardiac-related deaths at a mean follow-up of 21.2 +/- 10.7 months. The actuarial survival was 92.0% at 45 months. Freedom from death or cardiac events was 88.1% at 45 months.
CONCLUSIONS: Coronary artery reconstruction, with or without endarterectomy, using the left internal thoracic artery for a diffusely diseased LAD can be performed with acceptable early and midterm results.

Entities:  

Mesh:

Year:  2005        PMID: 16305852     DOI: 10.1016/j.athoracsur.2005.06.047

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  7 in total

Review 1.  Coronary endarterectomy for the diffusely diseased coronary artery.

Authors:  Kosaku Nishigawa; Toshihiro Fukui; Shuichiro Takanashi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-05-10

2.  Early and long-term outcomes of coronary artery bypass grafting and percutaneous coronary intervention in patients with left main disease: single-center results of multidisciplinary decision making.

Authors:  Toshihiro Fukui; Minoru Tabata; Tetsuya Tobaru; Ryuta Asano; Shuichiro Takanashi; Tetsuya Sumiyoshi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-12-08

3.  Surgical management of diffusely diseased coronary arteries.

Authors:  Gutti Ramasubrahmanyam; Karthik Panchanatheeswaran; Tej Kumar Varma Kalangi; Goli Nagasaina Rao
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2019-01-07

4.  Long Segmental Reconstruction of Diffusely Diseased Left Anterior Descending Coronary Artery Using Left Internal Thoracic Artery with Extensive Endarterectomy.

Authors:  Woon Heo; Ho-Ki Min; Do Kyun Kang; Sung Kwang Lee; Hee Jae Jun; Youn-Ho Hwang
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2015-08-05

5.  Coronary flow reserve in patients with left anterior descending artery-left internal mammary artery long patch plasty anastomosis: a prospective study.

Authors:  Ismail Haberal; Onur Gurer; Deniz Ozsoy; Esra Erturk
Journal:  J Cardiothorac Surg       Date:  2015-04-02       Impact factor: 1.637

6.  Short- and Long-Term Patient Outcomes From Combined Coronary Endarterectomy and Coronary Artery Bypass Grafting: A Meta-Analysis of 63,730 Patients (PRISMA).

Authors:  Jiayang Wang; Chengxiong Gu; Wenyuan Yu; Mingxin Gao; Yang Yu
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

7.  The midterm results of coronary endarterectomy in patients with diffuse coronary artery disease.

Authors:  Zhibing Qiu; L Auchoybur Merveesh; Yueyue Xu; Yinshuo Jiang; Liming Wang; Ming Xu; Fei Xiang; Xin Chen
Journal:  J Cardiothorac Surg       Date:  2018-07-24       Impact factor: 1.637

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.